Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles
Authors
Keywords
Lipid-based nanoparticle, siRNA, Targeting, Head and neck cancer, HPV
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 337, Issue -, Pages 378-389
Publisher
Elsevier BV
Online
2021-07-23
DOI
10.1016/j.jconrel.2021.07.034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
- (2020) Nuphar Veiga et al. ADVANCED DRUG DELIVERY REVIEWS
- Paving the Road for RNA Therapeutics
- (2020) Niels Dammes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Small Delivery Vehicles of siRNA for Enhanced Cancer Targeting
- (2018) Hyun Jin Kim et al. BIOMACROMOLECULES
- Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis
- (2018) Toshihiko Tashima BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A modular platform for targeted RNAi therapeutics
- (2018) Ranit Kedmi et al. Nature Nanotechnology
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
- (2018) Maura L Gillison et al. LANCET
- E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
- (2017) Shanthi Marur et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
- (2017) Katyayani Tatiparti et al. Nanomaterials
- The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma
- (2016) Daisuke Sano et al. International Journal of Clinical Oncology
- Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes
- (2016) Haruka Nishida et al. JOURNAL OF CONTROLLED RELEASE
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses
- (2015) Lifang Zhang et al. Molecular Cancer
- Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines
- (2015) Ingrid Fumagalli et al. OncoTargets and Therapy
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of HPV-associated oropharyngeal cancer
- (2014) Kristen B. Pytynia et al. ORAL ONCOLOGY
- Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines
- (2013) Zainal Adhim et al. ACTA OTO-LARYNGOLOGICA
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest
- (2013) Changyou Li et al. CELL CYCLE
- Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology
- (2013) Lígia Catarina Gomes-da-Silva et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- Analysis on the current status of targeted drug delivery to tumors
- (2012) Il Keun Kwon et al. JOURNAL OF CONTROLLED RELEASE
- Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
- (2011) Jinjun Shi et al. ACCOUNTS OF CHEMICAL RESEARCH
- Special delivery: targeted therapy with small RNAs
- (2011) D Peer et al. GENE THERAPY
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16
- (2011) Craig D. Woodworth et al. VIROLOGY
- Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models
- (2010) S Y Wu et al. GENE THERAPY
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
- (2009) Merrill S. Kies et al. JOURNAL OF CLINICAL ONCOLOGY
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started